Increased risk of depression may affect patient desire for face-to-face contact, hinder diabetes care…
Read More »Diabetes In Control
Autoantibodies Possible Predictors of Type 1 Diabetes in Children
Diesease progression possible with presence of two or more autoantibodies… Autoimmune type 2 diabetes is preceded by the appearance of islet insulin autoantibodies: GAD autoantibodies (GADAs), insulinoma-associated protein 2 autoantibodies (IA-2AS), and zinc transporter 8 autoantibodies. Previous studies show that diabetes will develop within 10 years in 27-40% of children with …
Read More »Microvascular Complications Due to Celiac Disease and Type 1 Diabetes
Studies yet to determine if gluten-free diet will decrease risk of retinopathy, nephropathy… Celiac Disease (CD) and type 1 diabetes are frequently associated with each other, as they have common genetic disorders. Current guidelines recommend screening patients with new onset diabetes for celiac disease and regularly thereafter. New studies have …
Read More »Increased Testosterone Linked to Diabetes and Prostate Enlargement
More long-term studies necessary to assess safety, efficacy of testosterone-replacement therapy… University of California researchers conducted saliva tests on 350 adult males in the Tsimane tribe, an isolated population in the Bolivian rainforest. Advanced cases of prostate enlargement were found to be virtually non-existent, with the Tsimane also observed to …
Read More »Fewer Behavioral Issues Linked to Omega-3 Fatty Acids
Children 8 to 16 who were given extra omega-3 for six months showed fewer emotional and behavioral issues, according to a study. Researchers said the children showed continued improvements in their behavior even after they stopped taking the extra omega-3. — Journal of Child Psychology and Psychiatry, Volume 56, Issue …
Read More »PPAR Agonist Safe for Type 2’s
Type 2 diabetes patients showed declines in their A1C, fasting glucose, triglycerides and non-HDL cholesterol levels after nine months of daily treatment of saroglitazar, a dual peroxisome proliferator-activated receptor-agonist. The findings also revealed that the drug did not cause any serious adverse events and was well tolerated by the patients. …
Read More »Older Diabetes Patients Can Lower A1C with Early Insulin Initiation
Early insulin initiation significantly lowered A1C levels and increased odds of reaching less than 8% A1C levels among type 2 diabetes patients older than 65 who also took oral antidiabetes drugs, compared to those who delayed insulin initiation. Researchers found no significant differences in hypoglycemia events or total costs between …
Read More »The Bionic Pancreas
A collaborative group from Boston University and Massachusetts General Hospital are working together to make automated blood glucose control a reality. Engineers from Boston University have developed a bionic pancreas system that uses continuous glucose monitoring along with subcutaneous delivery of both rapid-acting insulin (to lower blood glucose) and glucagon …
Read More »Letter from the Editor, #782
Steve and I got a chance to talk to Edward Damiano, PhD, from Boston University about his work on the "Bionic Pancreas" while we were at the recent AACE meeting in Nashville. We have all seen a lot of information using CGMS and an insulin pump to automatically adjust insulin …
Read More »Editor’s Note, GLP-1 Analogs May 2015 Special Edition
This past weekend I was at the ADA regional meeting in Orlando. There were over 600 medical professional attendees, and over 40 presentations on medications and of those 28 had content on GLP-1 analogs. I got a chance to share with 200 attendees the real story on how the first …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.